Another nail has been hammered into the coffin of the pharma model of providing lavish entertainment and other benefits to doctors to encourage prescribing of medicines.
Novartis and eyecare spinout Alcon have agreed to settle bribery charges brought by the US federal authorities, focused on activities in Greece and other countries, for $347 mi